CHE
CHEMED CORP
NYSE · Healthcare · Medical - Care Facilities · US
$548.64
+2.81%Year over year
Reported trailing growth
- Revenue
- +5.2%
- EBITDA
- +1.8%
- EBIT
- +5.5%
- EPS
- +10.0%
- Free cash flow
- -18.0%
- Operating cash flow
- -13.5%
Forward estimates
Based on analyst estimates
- Revenue
- +8.1%
- EBITDA
- +21.7%
- EPS
- +29.2%
Three-year CAGR
- Revenue
- +5.8%
- EBITDA
- +2.4%
- EBIT
- -0.5%
- Net income
- +2.0%
- EPS
- +3.3%
- Free cash flow
- +8.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026